跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cefbuperazone
首页
药物
Cefbuperazone
Experimental
Small Molecule
Cefbuperazone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
22
H
29
N
9
O
9
S
2
CAS 编号
76610-84-9
UNII ID
T0785J3X40
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation for cefbuperazone sodium
CN 101274937 A
申请人: FUXIN BROAD PHARMACEUTICAL CO
优先权: 2007
CN
Refining method of cefbuperazone intermediate
CN 101279981 B
申请人: NANJING HAILING HERBAL MEDICINE TECHNOLOGY RES CO LTD
优先权: 2008
CN
Cefbuperazone composition
CN 101919863 A
申请人: BEIJING LEADINGPHARM MEDICAL TECHNOLOGY CO LTD
优先权: 2009
CN
Preparation method for cefbuperazone
CN 102212075 A
申请人: SHANGHAI ANHANTE BIOPHARM TECHNOLOGY CO LTD
优先权: 2010
CN
Novel crystal form of cefbuperazone sodium and preparation method thereof
CN 103172647 A
申请人: GUILIN PHARMACEUTICAL CO LTD
优先权: 2011
CN
Preparation method of cefbuperazone side chain
CN 102838551 A
申请人: HARBIN PHARMACEUTICAL GROUP CO LTD GENERAL PHARMACEUTICAL FACTORY
优先权: 2012
CN
Preparation technology for cefbuperazone sodium
CN 103570747 A
申请人: ANHUI YOUCARE KAIYUE PHARMACEUTICAL CO LTD
优先权: 2013
CN
Synthesis method of cefbuperazone
CN 111039957 A
申请人: JIANGSU HI STONE PHARMACEUTICAL CO LTD
优先权: 2019
CN
Preparation method of cefbuperazone sodium salt
CN 111116612 A
申请人: JIANGSU HI-STONE PHARMACEUTICAL CO LTD
优先权: 2019
CN
药物
反馈